Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats

Overview

Journal Front Cell Neurosci

Specialty Cell Biology

Date 2022 Jun 9

PMID 35677756

Authors

Philippe De Deurwaerdere

Maurizio Casarrubea

Daniel Cassar

Manuela Radic

Emilie Puginier

Abdeslam Chagraoui

Giuseppe Crescimanno

Vincenzo Crunelli

Giuseppe Di Giovanni

Affiliations

Soon will be listed here.

Abstract

Childhood absence epilepsy (CAE) is characterized by absence seizures, which are episodes of lack of consciousness accompanied by electrographic spike-wave discharges. About 60% of children and adolescents with absence seizures are affected by major neuropsychological comorbidities, including anxiety. Endocannabinoids and monoamines are likely involved in the pathophysiology of these CAE psychiatric comorbidities. Here, we show that the synthetic cannabinoid receptor type 1/2 (CB1/2R) agonist WIN 55,212-2 (2 mg/kg) has a strain-dependent effect on anxiety-like and motor behavior when assess in the hole board test and cerebral monoaminergic levels in Genetic Absence Epilepsy Rats from Strasbourg (GAERS) and their non-epileptic control (NEC) rat strain. Using quantitative and Temporal pattern (T-pattern) analyses, we found that WIN 55,212-2 did not affect the emotional status of GAERS, but it was anxiolytic in NEC. Conversely, WIN 55,212-2 had a sedative effect in GAERS but was ineffective in NEC. Moreover, vehicle-treated GAERS more motivated to explore by implementing more complex and articulated strategies. These behavioral changes correlate with the reduction of 5-HT in the hippocampus and substantia nigra (SN) and noradrenaline (NA) in the entopeduncular nucleus (EPN) in vehicle-treated GAERS compared to NEC rats, which could contribute to their low anxiety status and hypermotility, respectively. On the other hand, the increased level of NA in the EPN and 5-HT in the SN is consistent with an activation of the basal ganglia output-mediated motor suppression observed in WIN 55,212-2-treated GAERS rats. These data support the view of a strain-dependent alteration of the endocannabinoid system in absence epilepsy by adding evidence of a lower emotional responsiveness and a basal ganglia hypersensitivity to cannabinoids in GAERS compared to NEC rats.

Citing Articles

A quantitative and T-pattern analysis of anxiety-like behavior in male GAERS, NEC, and Wistar rats bred under the same conditions, against a commercially available Wistar control group in the hole board and elevated plus maze tests.

Casarrubea M, Radic M, Morais T, Mifsud E, Cuboni E, Aiello S CNS Neurosci Ther. 2023; 30(3):e14443.

PMID: 37658671 PMC: 10916429. DOI: 10.1111/cns.14443.

References

Zimmer A, Zimmer A, Hohmann A, Herkenham M, Bonner T . Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci U S A. 1999; 96(10):5780-5. PMC: 21937. DOI: 10.1073/pnas.96.10.5780. View

Studer F, Laghouati E, Jarre G, David O, Pouyatos B, Depaulis A . Sensory coding is impaired in rat absence epilepsy. J Physiol. 2018; 597(3):951-966. PMC: 6355637. DOI: 10.1113/JP277297. View

Cope D, Di Giovanni G, Fyson S, Orban G, Errington A, Lorincz M . Enhanced tonic GABAA inhibition in typical absence epilepsy. Nat Med. 2009; 15(12):1392-8. PMC: 2824149. DOI: 10.1038/nm.2058. View

Roebuck A, Greba Q, Onofrychuk T, McElroy D, Sandini T, Zagzoog A . Dissociable changes in spike and wave discharges following exposure to injected cannabinoids and smoked cannabis in Genetic Absence Epilepsy Rats from Strasbourg. Eur J Neurosci. 2020; 55(4):1063-1078. DOI: 10.1111/ejn.15096. View

Arnold J, Topple A, Mallet P, Hunt G, McGregor I . The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. Brain Res. 2001; 921(1-2):240-55. DOI: 10.1016/s0006-8993(01)03127-4. View

Tanda G, Pontieri F, Di Chiara G . Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science. 1997; 276(5321):2048-50. DOI: 10.1126/science.276.5321.2048. View

Li Y, Kim J . CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory. Neural Plast. 2016; 2016:9817089. PMC: 4706977. DOI: 10.1155/2016/9817089. View

Yague J, Cavaccini A, Errington A, Crunelli V, Di Giovanni G . Dopaminergic modulation of tonic but not phasic GABAA-receptor-mediated current in the ventrobasal thalamus of Wistar and GAERS rats. Exp Neurol. 2013; 247:1-7. DOI: 10.1016/j.expneurol.2013.03.023. View

Deransart C, Depaulis A . The control of seizures by the basal ganglia? A review of experimental data. Epileptic Disord. 2002; 4 Suppl 3:S61-72. View

10.

Jones N, Salzberg M, Kumar G, Couper A, Morris M, OBrien T . Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation. Exp Neurol. 2007; 209(1):254-60. DOI: 10.1016/j.expneurol.2007.09.026. View

11.

De Giacomo V, Ruehle S, Lutz B, Haring M, Remmers F . Differential glutamatergic and GABAergic contributions to the tetrad effects of Δ-tetrahydrocannabinol revealed by cell-type-specific reconstitution of the CB1 receptor. Neuropharmacology. 2020; 179:108287. DOI: 10.1016/j.neuropharm.2020.108287. View

12.

Coenen A, van Luijtelaar E . Genetic animal models for absence epilepsy: a review of the WAG/Rij strain of rats. Behav Genet. 2003; 33(6):635-55. DOI: 10.1023/a:1026179013847. View

13.

McCormick D . Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog Neurobiol. 1992; 39(4):337-88. DOI: 10.1016/0301-0082(92)90012-4. View

14.

Tolmacheva E, Oitzl M, van Luijtelaar G . Stress, glucocorticoids and absences in a genetic epilepsy model. Horm Behav. 2012; 61(5):706-10. DOI: 10.1016/j.yhbeh.2012.03.004. View

15.

Villas-Boas G, Lavorato S, Paes M, Carvalho P, Rescia V, Cunha M . Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence. Pharmaceuticals (Basel). 2021; 14(2). PMC: 7918669. DOI: 10.3390/ph14020148. View

16.

Kliethermes C, Crabbe J . Genetic independence of mouse measures of some aspects of novelty seeking. Proc Natl Acad Sci U S A. 2006; 103(13):5018-23. PMC: 1405908. DOI: 10.1073/pnas.0509724103. View

17.

Perescis M, Flipsen N, van Luijtelaar G, van Rijn C . Altered SWD stopping mechanism in WAG/Rij rats subchronically treated with the cannabinoid agonist R(+)WIN55,212-2. Epilepsy Behav. 2019; 102:106722. DOI: 10.1016/j.yebeh.2019.106722. View

18.

Powell K, Tang H, Ng C, Guillemain I, Dieuset G, Dezsi G . Seizure expression, behavior, and brain morphology differences in colonies of Genetic Absence Epilepsy Rats from Strasbourg. Epilepsia. 2014; 55(12):1959-68. DOI: 10.1111/epi.12840. View

19.

Iffland K, Grotenhermen F . An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. Cannabis Cannabinoid Res. 2017; 2(1):139-154. PMC: 5569602. DOI: 10.1089/can.2016.0034. View

20.

Shaw F, Chuang S, Shieh K, Wang Y . Depression- and anxiety-like behaviors of a rat model with absence epileptic discharges. Neuroscience. 2009; 160(2):382-93. DOI: 10.1016/j.neuroscience.2009.02.053. View